Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Assertio Therapeutics, Inc
| Metric | Assertio Therapeutics, Inc Healthcare |
|---|---|
| Quality Score | 40 / 100 |
| Revenue (latest) | $58M |
| Net income (latest) | −$14M |
| Operating margin | 5.3% |
| Net margin | −24.7% |
| Return on equity | −24.7% |
| Return on assets | −2.7% |
| Return on capital (ROCE) | 0.9% |
| Debt / equity | 8.10× |
| Revenue growth (YoY) | −54.9% |
| Altman Z″ (distress) | -3.31 |
| Accruals / assets | −19.9% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.